ACTG 219: PEDIATRIC LATE OUTCOMES-INFANTS AND CHILDREN WITH HIV INFECTION

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 该方案的目的是确定HIV感染及其药物治疗的远期结果，包括对生长、神经功能、发育、恶性肿瘤的发生以及免疫学和病毒学参数的影响。这是一项正在进行的研究，需要数年时间才能完成。将获得的信息将对儿科研究人员非常有用。 这一方案现在已被列入艾滋病毒-1感染并发症的新分组。研究包括长期(24年)的随访研究。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The object of this protocol is to define late outcomes of HIV infection and its drug therapy, including effects on growth, neurologic function, development, occurrence of malignancy, and immunologic and virologic parameters. This is an on-going study that will take several years to complete. The information to be gained will be extremely useful to pediatric researchers. This protocol has now been placed in the new grouping of complications of HIV-1 infection. Studies involve long-term (24 year) follow-up studies.